Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. - sprookjes - yvandenbroek - TriplyDB

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

http://www.wikidata.org/entity/Q34127482

about

Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran The Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future use Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review Measurement characteristics of the childhood Asthma-Control Test and a shortened, child-only version Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.Gastro-oesophageal reflux and worse asthma control in obese children: a case of symptom misattribution?Predictors of asthma exacerbation among patients with poorly controlled asthma despite inhaled corticosteroid treatment.Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma.Exhaled breath condensate pH does not discriminate asymptomatic gastroesophageal reflux or the response to lansoprazole treatment in children with poorly controlled asthma.The sensitivity of acoustic cough recording relative to intraesophageal pressure recording and patient report during reflux testing.Validation and psychometric properties of the Asthma Control Questionnaire among children.Obesity in children with poorly controlled asthma: Sex differences ALOX5 polymorphism associates with increased leukotriene production and reduced lung function and asthma control in children with poorly controlled asthma Physical deconditioning as a cause of breathlessness among obese adolescents with a diagnosis of asthma.New developments in extraesophageal reflux disease.Biologic mechanisms of environmental tobacco smoke in children with poorly controlled asthma: results from a multicenter clinical trial Coexisting chronic conditions associated with mortality and morbidity in adult patients with asthma.Managing the pediatric patient with refractory asthma: a multidisciplinary approach.Effectiveness of montelukast administered as monotherapy or in combination with inhaled corticosteroid in pediatric patients with uncontrolled asthma: a prospective cohort study Infection-related asthma.Advances in pediatric pharmacology, therapeutics, and toxicology.Residential proximity to a major roadway is associated with features of asthma control in children.H+/K+-ATPase inhibitors: a patent review.A tutorial on sensitivity analyses in clinical trials: the what, why, when and how.16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal microflora.Pharmacodynamic effects of oral oxymorphone: abuse liability, analgesic profile and direct physiologic effects in humans.Update in asthma 2011.Severe asthma in children.Is There a Relationship Between GERD and Asthma?Nutrigenetic response to omega-3 fatty acids in obese asthmatics (NOOA): rationale and methods Changes in gastric and lung microflora with acid suppression: acid suppression and bacterial growth.Failure of proton pump inhibitors to treat GERD in neonates and infants: a question of drug, diagnosis, or design.Difficult-to-treat asthma in childhood.Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease.Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment.Management of severe asthma in childhood--state of the art and novel perspectives.Unmet therapeutic needs in eosinophilic esophagitis Asthma control questionnaires in the management of asthma in children: A review.Safety of medication options for treating pediatric esophagitis.

P2860

Q26777154-175B314C-3D6F-49B1-8111-469C04BBCF36 Q27025354-E5CDA076-A050-4DBD-8A99-84B517781562 Q28082238-67BB386B-2AC7-4302-B9A6-236063DF47AB Q30275671-789F8F77-611A-4C7B-B0AB-4D81D8BA7AA8 Q30276073-D4D547CE-9BE0-4816-A7E5-DA0388B058B2 Q30277630-947983CA-72C9-4908-BCF0-1D929EE8CF86 Q30277850-B54F964A-B013-4B75-8D29-D860BCD6891F Q30300235-DA3CE175-BFCE-4A67-90E8-3CA1E74DDBA9 Q30360466-CEBDF784-354F-4AF0-AE9A-BB4B6ECE508E Q30371124-126A00DC-85DD-4265-BED8-4D30CC7D138C Q30399991-8DE7DC5F-6DE2-4EEC-BAD1-E0128C54C39D Q30408801-00C2FAE7-DC7E-42B8-A1ED-E07FCEDB1C50 Q30411099-34F3A450-B2EB-4FF7-A0F3-B5693E3F52BD Q30413299-1D69B7F8-DFD1-4BB2-B46E-510F75C7A6EB Q30419689-0C2ED049-8C51-4F84-863E-C81EA17C51B1 Q30457464-48F61861-DABE-4A64-978E-201965CC31F5 Q30457498-9C830F49-34CA-457E-A1B0-61B74F5667BF Q30581306-4616FF4A-ACFB-4C39-B327-16F79778A8D2 Q33602567-E4083FF1-E569-4606-84C7-8026D0961692 Q33755127-3C703CE3-FD76-4A96-84F2-228287B59AC4 Q33917155-A48030C5-4711-45A5-A1CD-147E803E8BC7 Q33998667-06D495F2-3CE4-412F-8C19-7833623BD4FE Q34277666-CAA1F6EA-9C34-4945-8417-B8120CB491AD Q34315036-6B8074EB-0EE8-4896-AAE5-DA6571CE9004 Q34819923-4BF79FB7-3036-4E71-88DC-A80D5677C4A3 Q35235645-55A877DA-7F39-43DA-9743-B51B8AD2D272 Q35252121-01D9FE09-8EFA-48B9-83C9-41D5360B75D9 Q36105881-8D2092B2-7C86-4DC7-A759-7FB56FD8321E Q36108246-6630F1B4-011F-4579-B58F-6EC36A780129 Q36180000-C223629F-F1A6-4A4B-9F0E-50BBDFE42098 Q36800748-A8ACE395-F880-4377-8D39-E2BC7480B0D7 Q37402038-42B0B1FD-404B-4C19-BB05-C1A7CA887F17 Q38026988-5D6F0DC6-6B3D-4AD2-A86F-315044764312 Q38098097-9B11F17C-B30A-4C5A-ADA5-FA30FC23D0C8 Q38109860-5FB3E1AF-3E38-4C2C-8916-2E6CFCC6512A Q38123751-121A513B-5682-4767-AE90-479CE412E4E0 Q38150455-56F653A0-B6FF-4B17-B5C8-7901352555D3 Q38194025-D5F50B54-65E6-4EA3-91E7-9A60D4BB74B5 Q38245983-7D8C127B-6657-480F-89C0-D81ED2CE41D5 Q38442609-E1A151E8-1AE9-4B0E-A9BF-6E187FEACA2B

P2860

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

http://www.wikidata.org/entity/Q34127482

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

@ast

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

@en

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

@nl

type

label

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

@ast

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

@en

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

@nl

prefLabel

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

@ast

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

@en

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

@nl

P1433

Q34127482-7F444E7F-EEEA-4EAC-B842-D0F742302328

P1476

Q34127482-1F274C8B-48D3-4382-A369-B5D5B6D78026

P2093

Q34127482-2BE403E2-4948-42AB-99F7-E936F1FD8A3F

Q34127482-3BE968A9-3C49-493D-84FD-200F785C3FF2

Q34127482-4B04715C-93F7-4FCD-BEA7-7C9390B73E92

Q34127482-4C4DD36B-5464-4C86-9F54-2157C580962F

Q34127482-A4F045E9-ECA0-4308-8A6D-FBF34268464D

Q34127482-B74BF3B5-138D-452B-83DF-2D0712B67204

Q34127482-CE628654-9067-499E-92ED-48B9123D041E

Q34127482-D239DE65-9BF6-4AE3-AC59-4B72E016FC6E

Q34127482-E006C42C-2B1E-4DC9-A685-8B1CB6635A4F

Q34127482-E77964C9-008E-4642-910E-92A9EB7878D4

P2860

Q34127482-0EF916E5-7562-4F45-A9FC-FE7CBAE0444A

Q34127482-1AF8461C-0513-4EEF-A103-0CCF9EBC7B44

Q34127482-1C0E6B22-FB2E-4D84-AA13-8DBF24423F92

Q34127482-2DBF04F2-7361-4942-939D-6BC8F121D34C

Q34127482-3A271B26-0EAC-4B7A-A012-3588D1B2AEA4

Q34127482-40213212-CA03-41EE-974A-F61A11183497

Q34127482-465ADF3B-A0FB-4DAB-9D57-991F1A8760FA

Q34127482-4875FF06-FA48-4CF8-97BD-922CA200BB27

Q34127482-5382B5FD-B451-4B91-96F5-BA8A73A80F05

Q34127482-538934A0-A36B-4B76-98E0-363D35A3DB70

P304

Q34127482-10E0C752-2843-46B4-9FD0-8FA51146D001

P31

Q34127482-77F3C610-D13F-4F1F-849E-5CA808D925D7

P356

Q34127482-48628283-B01C-4968-B9C7-47EF2C905F93

P407

Q34127482-19A465BF-8FCD-4BAF-B375-53A4158CEF1A

P433

Q34127482-B4032133-435C-48BF-81FD-6496767A110D

P478

Q34127482-14DBAD17-3CD4-42E6-906C-AFF41E5084E9

P50

Q34127482-85427F64-2552-4A7A-B6C5-F4870E233A4C

Q34127482-855BF377-5FB3-4E5C-A162-8924C9F24E0B

P577

Q34127482-4541C83F-D35B-4231-A0FF-7301382B8AC9

P5875

Q34127482-E900DF23-1CA4-42A4-974D-78062F61D10B

P698

Q34127482-95DED902-014F-4251-81CB-6254FC574A3B

P921

Q34127482-AC9BEFA8-F65E-48E0-B920-7F4E1E3EA189

P932

Q34127482-D177D208-1C7A-4E2C-B02F-C82FD35E41D2

P356

P1433

Journal of the American Medical Association

P1476

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

@en

P2093

Allen J Dozor

http://www.w3.org/2001/XMLSchema#string

Benjamin D Gold

http://www.w3.org/2001/XMLSchema#string

Ellen D Brown

http://www.w3.org/2001/XMLSchema#string

Janet T Holbrook

http://www.w3.org/2001/XMLSchema#string

John G Mastronarde

http://www.w3.org/2001/XMLSchema#string

John J Lima

http://www.w3.org/2001/XMLSchema#string

Marianna M Sockrider

http://www.w3.org/2001/XMLSchema#string

Mario Castro

http://www.w3.org/2001/XMLSchema#string

W Gerald Teague

http://www.w3.org/2001/XMLSchema#string

Writing Committee for the American Lung Association Asthma Clinical Research Centers

http://www.w3.org/2001/XMLSchema#string

P2860

Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis

Spirometric reference values from a sample of the general U.S. population

Longitudinal data analysis for discrete and continuous outcomes

Efficacy of esomeprazole for treatment of poorly controlled asthma.

Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity.

Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.

Associations between respiratory symptoms, lung function and gastro-oesophageal reflux symptoms in a population-based birth cohort.

Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease.

Systematic review: the extra-oesophageal symptoms of gastro-oesophageal reflux disease in children.

P304

373-381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2011.2035

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

307

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221774938

http://www.w3.org/2001/XMLSchema#string

P698

22274684

http://www.w3.org/2001/XMLSchema#string

P921

P932

4153372

http://www.w3.org/2001/XMLSchema#string